Vascular Dysfunction in Glycogen Storage Disease Type I

Journal of Pediatrics

Volumn 154, Issue 4, 2009, Pages 588-591

  Bernier, Angelina V ^a   Correia, Catherine E ^a   Haller, Michael J ^a   Theriaque, Douglas W ^b   Shuster, Jonathan J ^b   Weinstein, David A ^a  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTERY DIAMETER; ARTERY INTIMA; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROL GROUP; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIAL ARTERY; RISK ASSESSMENT; TONOMETRY; VASCULAR DISEASE;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FLORIDA; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; MALE; MANOMETRY; RADIAL ARTERY; RISK; TUNICA INTIMA;

EID: 62649169118     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.10.048     Document Type: Article

References (20)

1. Wolfsdorf J.I., and Weinstein D.A. Glycogen storage diseases. Rev Endocr Metab Disord 4 (2003) 95-102
2. Levy E., Letarte J., Lepage G., Thibault L., and Roy C.C. Plasma and lipoprotein fatty acid composition in glycogen storage disease type I. Lipids 22 (1987) 381-385
3. Ubels F.L., Rake J.P., Slaets J.P., Smit G.P., and Smit A.J. Is glycogen storage disease 1a associated with atherosclerosis?. Eur J Pediatr 161 (2002) S62-S64
4. Lee P.J., Celermajer D.S., Robinson J., McCarthy S.N., Betteridge D.J., and Leonard J.V. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110 (1994) 95-100
5. Nguyen A.D., Pan C.J., Weinstein D.A., and Chou J.Y. Increased scavenger receptor class B type 1-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Mol Genet Metab 89 (2006) 233-238
6. Wittenstein B., Klein M., Finckh B., Ullrich K., and Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33 (2002) 103-110
7. Muhlhausen C., Schneppenheim R., Budde U., Merkel M., Muschol N., Ullrich K., et al. Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28 (2005) 945-950
8. Russo G., Leopold J.A., and Loscalzo J. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vasc Pharmacol 38 (2002) 259-269
9. Fathi R., and Marwick T.H. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J 141 (2001) 694-703
10. van Dam M.J., de Groot E., Clee S.M., Hovingh G.K., Roelants R., Brooks-Wilson A., et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359 (2002) 37-42
11. Slyper A.H. Clinical review 168: what vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 89 (2004) 3089-3095
12. Elpeleg O.N. The molecular background of glycogen metabolism disorders. J Pediatr Endocrinol Metab 12 (1999) 363-379
13. Haller M.J., Samyn M., Nichols W.W., Brusko T., Wasserfall C., Schwartz R.F., et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 27 (2004) 2911-2917
14. Lippi G., Montagnana M., Franchini M., Favaloro E.J., and Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 392 (2008) 1-7
15. McDonald L., and Edgill M. Changes in coagulability of the blood during various phases of ischaemic heart-disease. Lancet 1 (1959) 1115-1118
16. Marfaing-Koka A., Wolf M., Boyer-Neumann C., Meyer D., Odievre M., and Labrune P. Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia. J Pediatr Gastroenterol Nutr 37 (2003) 566-570
17. Fielding C.J., and Fielding P.E. Cellular cholesterol efflux. Biochem Biophys Acta 1533 (2001) 175-189
18. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
19. Bandsma R.H., Prinsen B.H., van Der Velden Mde S., Rake J.P., Boer T., Smit G.P., et al. Increased de novo lipogenesis and delayed conversion of large VLDL into IDL particles contribute to hyperlipidemia in Glycogen Storage Disease type 1a. Pediatr Res 63 (2008) 702-707
20. Shek A., and Ferrill M.J. Statin-fibrate combination therapy. Ann Pharmacother 35 (2001) 908-917